ISSN: 2791-7967
The Effect of COVID-19 in Patients with Allergic Rhinitis
PDF
Cite
Share
Request
Original Article
VOLUME: 3 ISSUE: 3
P: 88-92
November 2022

The Effect of COVID-19 in Patients with Allergic Rhinitis

J Eur Med Sci 2022;3(3):88-92
DOI: 10.5578/jeurmeds.20220302
Sedat ALAGÖZ 1
Vedat DELİBAŞ 1
Kemal Koray BAL 2
Nur YÜCEL EKİCİ 1
Talih ÖZDAŞ 1
Gökhan KURAN 1
Orhan GÖRGÜLÜ 3
1. Adana City Training and Research Hospital, Clinic of Otorhinolaryngology, Adana, Türkiye
2. Mersin University Hospital, Clinic of Otorhinolaryngologic Diseases, Mersin, Türkiye
3. Ortadoğu Private Hospital, Clinic of Otorhinolaryngology, Adana, Türkiye
No information available.
No information available
Received Date: 6.10.2022
Accepted Date: 26.11.2022
Online Date: 27.12.2022
PDF
Cite
Share
Request

ABSTRACT

Objective

Allergic rhinitis (AR) is a pathology in which the nasal mucosa becomes inflamed by hypersensitivity to pollen, dust, spores, and is often accompanied by symptoms such as sneezing, nasal itching, nasal congestion and runny nose. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), also known as COVID-19, is a type of coronavirus that has not been previously identified in humans. SARS-CoV-2 is now known as a highly contagious virus. Our aim in this study was to determine the possibility of COVID-19 infection in patients with allergic rhinitis and its relationship with smoking.

Material and Methods

This study covers the period between October 2020 and January 2021, and 100 adult patients who were followed up in our clinic with the diagnosis of allergic rhinitis for at least five years and used nasal steroids.

Results

Of the patients, 52 (51%) were male and 48 (49%) were female. The mean age was 37.04 ± 8.79. While 40 (40%) of the patients were smokers, 60 (60%) were non-smokers. COVID-19 positivity was detected in 9% of the patients. The frequency of COVID-19 infection in smokers was significantly lower than in non-smokers (p< 0.01). There was no significant difference in terms of COVID-19 positivity by gender (p= 0.305). The frequency of COVID-19 positivity was found to be significantly higher in patients with first-degree relatives infected with COVID-19 (p= 0.009). There was no difference in the frequency of COVID-19 infection in patients with and without COVID-19 positivity in the working environment (p= 0.597).

Conclusion

The COVID-19 pandemic threatens health worldwide. AR is a common disease in society. In our study, although the frequency of COVID-19 increased in AR patients with a first-degree relative with COVID-19 positivity, positivity in coworkers did not increase the frequency of COVID-19. Also, interestingly, COVID-19 infection was less common in smokers with AR.